These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 14687986

  • 1. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K, Pinto do O P, Hägglund AC, Wahlin A, Carlsson L.
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [Abstract] [Full Text] [Related]

  • 2. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
    Presley CA, Lee AW, Kastl B, Igbinosa I, Yamada Y, Fishman GI, Gutstein DE, Cancelas JA.
    Cell Commun Adhes; 2005 Oct 15; 12(5-6):307-17. PubMed ID: 16531325
    [Abstract] [Full Text] [Related]

  • 4. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW, Ren R.
    Oncogene; 2000 Dec 14; 19(54):6286-96. PubMed ID: 11175343
    [Abstract] [Full Text] [Related]

  • 5. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia.
    Cadieux C, Fournier S, Peterson AC, Bédard C, Bedell BJ, Nepveu A.
    Cancer Res; 2006 Oct 01; 66(19):9492-501. PubMed ID: 17018605
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
    Takahashi M, Fujiwara M.
    Rinsho Ketsueki; 1988 Jul 01; 29(7):994-1000. PubMed ID: 3184486
    [No Abstract] [Full Text] [Related]

  • 8. Differences between normal and CML stem cells: potential targets for clinical exploitation.
    Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer AL, Eaves CJ.
    Stem Cells; 1998 Jul 01; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
    [Abstract] [Full Text] [Related]

  • 9. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Jul 01; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 10. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
    van Pel M, Hagoort H, Hamann J, Fibbe WE.
    Haematologica; 2008 Aug 01; 93(8):1137-44. PubMed ID: 18603564
    [Abstract] [Full Text] [Related]

  • 11. Searching for leukemia stem cells--not yet the end of the road?
    Jordan CT.
    Cancer Cell; 2006 Oct 01; 10(4):253-4. PubMed ID: 17045202
    [Abstract] [Full Text] [Related]

  • 12. Chronic radiation-induced alteration in hematopoietic repair during preclinical phases of aplastic anemia and myeloproliferative disease: assessing unscheduled DNA synthesis responses.
    Seed TM, Meyers SM.
    Cancer Res; 1993 Oct 01; 53(19):4518-27. PubMed ID: 8402623
    [Abstract] [Full Text] [Related]

  • 13. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
    Yasuda T, Shirakata M, Iwama A, Ishii A, Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, Nakauchi H, Iwakura Y, Hirai H, Oda H, Yamamoto T, Yamanashi Y.
    J Exp Med; 2004 Dec 20; 200(12):1681-7. PubMed ID: 15611294
    [Abstract] [Full Text] [Related]

  • 14. [Clonality and stem cell defects in the molecular pathology of chronic myeloproliferative disorders].
    Kreipe H, Radzun HJ, Bartels H, von Heyden HW, Löffler H, Parwaresch MR.
    Verh Dtsch Ges Pathol; 1990 Dec 20; 74():49-64. PubMed ID: 1708635
    [Abstract] [Full Text] [Related]

  • 15. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
    Jiang X, Saw KM, Eaves A, Eaves C.
    J Natl Cancer Inst; 2007 May 02; 99(9):680-93. PubMed ID: 17470736
    [Abstract] [Full Text] [Related]

  • 16. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal.
    Chan RJ, Li Y, Hass MN, Walter A, Voorhorst CS, Shelley WC, Yang Z, Orschell CM, Yoder MC.
    Exp Hematol; 2006 Sep 02; 34(9):1230-9. PubMed ID: 16939816
    [Abstract] [Full Text] [Related]

  • 17. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
    Hosen N, Shirakata T, Nishida S, Yanagihara M, Tsuboi A, Kawakami M, Oji Y, Oka Y, Okabe M, Tan B, Sugiyama H, Weissman IL.
    Leukemia; 2007 Aug 02; 21(8):1783-91. PubMed ID: 17525726
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo.
    Yan XQ, Brady G, Iscove NN.
    Oncogene; 1994 Jan 02; 9(1):163-73. PubMed ID: 8302575
    [Abstract] [Full Text] [Related]

  • 19. Rho GTPases and regulation of hematopoietic stem cell localization.
    Williams DA, Zheng Y, Cancelas JA.
    Methods Enzymol; 2008 Jan 02; 439():365-93. PubMed ID: 18374178
    [Abstract] [Full Text] [Related]

  • 20. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
    Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC, Pendergast AM, Bronson R, Aster JC, Scott ML, Baltimore D.
    Blood; 1998 Nov 15; 92(10):3780-92. PubMed ID: 9808572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.